The move consolidates the two gastrointestinal brands with D'Arcy, which already is agency of record for the hoped-for over-the-counter version of Prilosec.
P&G has OTC conversion rights for Prilosec, marketed by AstraZeneca as a prescription drug, and has told financial analysts it hopes to receive approval for the OTC conversion by next year.
Klemtner Advertising, New York, handles the prescription Prilosec account for AstraZeneca. -- Jack Neff
Copyright July 2001, Crain Communications Inc.